Global OTC and DTC Infectious Disease Diagnostic Supply, Demand and Key Producers, 2023-2029
The global OTC and DTC Infectious Disease Diagnostic market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
In the manufacture and quality control of medicinal products, compliance with the GMP rules is the decisive aspect for manufacturing high-quality products. For this reason, every staff member in the pharmaceutical industry has to be familiar with the basic GMP requirements
This report studies the global OTC and DTC Infectious Disease Diagnostic demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for OTC and DTC Infectious Disease Diagnostic, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of OTC and DTC Infectious Disease Diagnostic that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global OTC and DTC Infectious Disease Diagnostic total market, 2018-2029, (USD Million)
Global OTC and DTC Infectious Disease Diagnostic total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: OTC and DTC Infectious Disease Diagnostic total market, key domestic companies and share, (USD Million)
Global OTC and DTC Infectious Disease Diagnostic revenue by player and market share 2018-2023, (USD Million)
Global OTC and DTC Infectious Disease Diagnostic total market by Technology, CAGR, 2018-2029, (USD Million)
Global OTC and DTC Infectious Disease Diagnostic total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global OTC and DTC Infectious Disease Diagnostic market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, Bio-Rad Laboratories Inc, BD, Bosch Healthcare Solutions GmbH, Danaher, ThermoFisher Scientific, Siemens AG, Roche Holding AG and Hologic, Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World OTC and DTC Infectious Disease Diagnostic market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Technology, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global OTC and DTC Infectious Disease Diagnostic Market, By Region:
1. How big is the global OTC and DTC Infectious Disease Diagnostic market?
2. What is the demand of the global OTC and DTC Infectious Disease Diagnostic market?
3. What is the year over year growth of the global OTC and DTC Infectious Disease Diagnostic market?
4. What is the total value of the global OTC and DTC Infectious Disease Diagnostic market?
5. Who are the major players in the global OTC and DTC Infectious Disease Diagnostic market?
6. What are the growth factors driving the market demand?
In the manufacture and quality control of medicinal products, compliance with the GMP rules is the decisive aspect for manufacturing high-quality products. For this reason, every staff member in the pharmaceutical industry has to be familiar with the basic GMP requirements
This report studies the global OTC and DTC Infectious Disease Diagnostic demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for OTC and DTC Infectious Disease Diagnostic, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of OTC and DTC Infectious Disease Diagnostic that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global OTC and DTC Infectious Disease Diagnostic total market, 2018-2029, (USD Million)
Global OTC and DTC Infectious Disease Diagnostic total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: OTC and DTC Infectious Disease Diagnostic total market, key domestic companies and share, (USD Million)
Global OTC and DTC Infectious Disease Diagnostic revenue by player and market share 2018-2023, (USD Million)
Global OTC and DTC Infectious Disease Diagnostic total market by Technology, CAGR, 2018-2029, (USD Million)
Global OTC and DTC Infectious Disease Diagnostic total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global OTC and DTC Infectious Disease Diagnostic market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, Bio-Rad Laboratories Inc, BD, Bosch Healthcare Solutions GmbH, Danaher, ThermoFisher Scientific, Siemens AG, Roche Holding AG and Hologic, Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World OTC and DTC Infectious Disease Diagnostic market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Technology, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global OTC and DTC Infectious Disease Diagnostic Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- PCR
- Immunodiagnostics
- Clinical Microbiology
- INAAT
- DNA Sequencing and NGS
- DNA Microarrays
- Others
- Diagnostic Laboratories
- Hospitals and Clinics
- Academic Research Institutes
- Others
- Abbott
- Bio-Rad Laboratories Inc
- BD
- Bosch Healthcare Solutions GmbH
- Danaher
- ThermoFisher Scientific
- Siemens AG
- Roche Holding AG
- Hologic, Inc.
- Qiagen
- Cardinal Health
- Quest Diagnostics Incorporated
- Ador Diagnostics
- Akonni Biosystems, Inc.
- Alveo Technologies
- Binx Health Inc.
- bioM?rieux, Inc.
- Curetis
- Sysmex Europe GmbH
- Diasorin S.p.A
1. How big is the global OTC and DTC Infectious Disease Diagnostic market?
2. What is the demand of the global OTC and DTC Infectious Disease Diagnostic market?
3. What is the year over year growth of the global OTC and DTC Infectious Disease Diagnostic market?
4. What is the total value of the global OTC and DTC Infectious Disease Diagnostic market?
5. Who are the major players in the global OTC and DTC Infectious Disease Diagnostic market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 OTC and DTC Infectious Disease Diagnostic Introduction
1.2 World OTC and DTC Infectious Disease Diagnostic Market Size & Forecast (2018 & 2022 & 2029)
1.3 World OTC and DTC Infectious Disease Diagnostic Total Market by Region (by Headquarter Location)
1.3.1 World OTC and DTC Infectious Disease Diagnostic Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States OTC and DTC Infectious Disease Diagnostic Market Size (2018-2029)
1.3.3 China OTC and DTC Infectious Disease Diagnostic Market Size (2018-2029)
1.3.4 Europe OTC and DTC Infectious Disease Diagnostic Market Size (2018-2029)
1.3.5 Japan OTC and DTC Infectious Disease Diagnostic Market Size (2018-2029)
1.3.6 South Korea OTC and DTC Infectious Disease Diagnostic Market Size (2018-2029)
1.3.7 ASEAN OTC and DTC Infectious Disease Diagnostic Market Size (2018-2029)
1.3.8 India OTC and DTC Infectious Disease Diagnostic Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 OTC and DTC Infectious Disease Diagnostic Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 OTC and DTC Infectious Disease Diagnostic Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World OTC and DTC Infectious Disease Diagnostic Consumption Value (2018-2029)
2.2 World OTC and DTC Infectious Disease Diagnostic Consumption Value by Region
2.2.1 World OTC and DTC Infectious Disease Diagnostic Consumption Value by Region (2018-2023)
2.2.2 World OTC and DTC Infectious Disease Diagnostic Consumption Value Forecast by Region (2024-2029)
2.3 United States OTC and DTC Infectious Disease Diagnostic Consumption Value (2018-2029)
2.4 China OTC and DTC Infectious Disease Diagnostic Consumption Value (2018-2029)
2.5 Europe OTC and DTC Infectious Disease Diagnostic Consumption Value (2018-2029)
2.6 Japan OTC and DTC Infectious Disease Diagnostic Consumption Value (2018-2029)
2.7 South Korea OTC and DTC Infectious Disease Diagnostic Consumption Value (2018-2029)
2.8 ASEAN OTC and DTC Infectious Disease Diagnostic Consumption Value (2018-2029)
2.9 India OTC and DTC Infectious Disease Diagnostic Consumption Value (2018-2029)
3 WORLD OTC AND DTC INFECTIOUS DISEASE DIAGNOSTIC COMPANIES COMPETITIVE ANALYSIS
3.1 World OTC and DTC Infectious Disease Diagnostic Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global OTC and DTC Infectious Disease Diagnostic Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for OTC and DTC Infectious Disease Diagnostic in 2022
3.2.3 Global Concentration Ratios (CR8) for OTC and DTC Infectious Disease Diagnostic in 2022
3.3 OTC and DTC Infectious Disease Diagnostic Company Evaluation Quadrant
3.4 OTC and DTC Infectious Disease Diagnostic Market: Overall Company Footprint Analysis
3.4.1 OTC and DTC Infectious Disease Diagnostic Market: Region Footprint
3.4.2 OTC and DTC Infectious Disease Diagnostic Market: Company Product Type Footprint
3.4.3 OTC and DTC Infectious Disease Diagnostic Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: OTC and DTC Infectious Disease Diagnostic Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: OTC and DTC Infectious Disease Diagnostic Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: OTC and DTC Infectious Disease Diagnostic Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: OTC and DTC Infectious Disease Diagnostic Consumption Value Comparison
4.2.1 United States VS China: OTC and DTC Infectious Disease Diagnostic Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: OTC and DTC Infectious Disease Diagnostic Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based OTC and DTC Infectious Disease Diagnostic Companies and Market Share, 2018-2023
4.3.1 United States Based OTC and DTC Infectious Disease Diagnostic Companies, Headquarters (States, Country)
4.3.2 United States Based Companies OTC and DTC Infectious Disease Diagnostic Revenue, (2018-2023)
4.4 China Based Companies OTC and DTC Infectious Disease Diagnostic Revenue and Market Share, 2018-2023
4.4.1 China Based OTC and DTC Infectious Disease Diagnostic Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies OTC and DTC Infectious Disease Diagnostic Revenue, (2018-2023)
4.5 Rest of World Based OTC and DTC Infectious Disease Diagnostic Companies and Market Share, 2018-2023
4.5.1 Rest of World Based OTC and DTC Infectious Disease Diagnostic Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies OTC and DTC Infectious Disease Diagnostic Revenue, (2018-2023)
5 MARKET ANALYSIS BY TECHNOLOGY
5.1 World OTC and DTC Infectious Disease Diagnostic Market Size Overview by Technology: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Technology
5.2.1 PCR
5.2.2 Immunodiagnostics
5.2.3 Clinical Microbiology
5.2.4 INAAT
5.2.5 DNA Sequencing and NGS
5.2.6 DNA Microarrays
5.2.7 Others
5.3 Market Segment by Technology
5.3.1 World OTC and DTC Infectious Disease Diagnostic Market Size by Technology (2018-2023)
5.3.2 World OTC and DTC Infectious Disease Diagnostic Market Size by Technology (2024-2029)
5.3.3 World OTC and DTC Infectious Disease Diagnostic Market Size Market Share by Technology (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World OTC and DTC Infectious Disease Diagnostic Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Diagnostic Laboratories
6.2.2 Hospitals and Clinics
6.2.3 Academic Research Institutes
6.2.4 Others
6.2.5 Others
6.3 Market Segment by Application
6.3.1 World OTC and DTC Infectious Disease Diagnostic Market Size by Application (2018-2023)
6.3.2 World OTC and DTC Infectious Disease Diagnostic Market Size by Application (2024-2029)
6.3.3 World OTC and DTC Infectious Disease Diagnostic Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Abbott
7.1.1 Abbott Details
7.1.2 Abbott Major Business
7.1.3 Abbott OTC and DTC Infectious Disease Diagnostic Product and Services
7.1.4 Abbott OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Abbott Recent Developments/Updates
7.1.6 Abbott Competitive Strengths & Weaknesses
7.2 Bio-Rad Laboratories Inc
7.2.1 Bio-Rad Laboratories Inc Details
7.2.2 Bio-Rad Laboratories Inc Major Business
7.2.3 Bio-Rad Laboratories Inc OTC and DTC Infectious Disease Diagnostic Product and Services
7.2.4 Bio-Rad Laboratories Inc OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Bio-Rad Laboratories Inc Recent Developments/Updates
7.2.6 Bio-Rad Laboratories Inc Competitive Strengths & Weaknesses
7.3 BD
7.3.1 BD Details
7.3.2 BD Major Business
7.3.3 BD OTC and DTC Infectious Disease Diagnostic Product and Services
7.3.4 BD OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 BD Recent Developments/Updates
7.3.6 BD Competitive Strengths & Weaknesses
7.4 Bosch Healthcare Solutions GmbH
7.4.1 Bosch Healthcare Solutions GmbH Details
7.4.2 Bosch Healthcare Solutions GmbH Major Business
7.4.3 Bosch Healthcare Solutions GmbH OTC and DTC Infectious Disease Diagnostic Product and Services
7.4.4 Bosch Healthcare Solutions GmbH OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Bosch Healthcare Solutions GmbH Recent Developments/Updates
7.4.6 Bosch Healthcare Solutions GmbH Competitive Strengths & Weaknesses
7.5 Danaher
7.5.1 Danaher Details
7.5.2 Danaher Major Business
7.5.3 Danaher OTC and DTC Infectious Disease Diagnostic Product and Services
7.5.4 Danaher OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Danaher Recent Developments/Updates
7.5.6 Danaher Competitive Strengths & Weaknesses
7.6 ThermoFisher Scientific
7.6.1 ThermoFisher Scientific Details
7.6.2 ThermoFisher Scientific Major Business
7.6.3 ThermoFisher Scientific OTC and DTC Infectious Disease Diagnostic Product and Services
7.6.4 ThermoFisher Scientific OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 ThermoFisher Scientific Recent Developments/Updates
7.6.6 ThermoFisher Scientific Competitive Strengths & Weaknesses
7.7 Siemens AG
7.7.1 Siemens AG Details
7.7.2 Siemens AG Major Business
7.7.3 Siemens AG OTC and DTC Infectious Disease Diagnostic Product and Services
7.7.4 Siemens AG OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Siemens AG Recent Developments/Updates
7.7.6 Siemens AG Competitive Strengths & Weaknesses
7.8 Roche Holding AG
7.8.1 Roche Holding AG Details
7.8.2 Roche Holding AG Major Business
7.8.3 Roche Holding AG OTC and DTC Infectious Disease Diagnostic Product and Services
7.8.4 Roche Holding AG OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Roche Holding AG Recent Developments/Updates
7.8.6 Roche Holding AG Competitive Strengths & Weaknesses
7.9 Hologic, Inc.
7.9.1 Hologic, Inc. Details
7.9.2 Hologic, Inc. Major Business
7.9.3 Hologic, Inc. OTC and DTC Infectious Disease Diagnostic Product and Services
7.9.4 Hologic, Inc. OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Hologic, Inc. Recent Developments/Updates
7.9.6 Hologic, Inc. Competitive Strengths & Weaknesses
7.10 Qiagen
7.10.1 Qiagen Details
7.10.2 Qiagen Major Business
7.10.3 Qiagen OTC and DTC Infectious Disease Diagnostic Product and Services
7.10.4 Qiagen OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Qiagen Recent Developments/Updates
7.10.6 Qiagen Competitive Strengths & Weaknesses
7.11 Cardinal Health
7.11.1 Cardinal Health Details
7.11.2 Cardinal Health Major Business
7.11.3 Cardinal Health OTC and DTC Infectious Disease Diagnostic Product and Services
7.11.4 Cardinal Health OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Cardinal Health Recent Developments/Updates
7.11.6 Cardinal Health Competitive Strengths & Weaknesses
7.12 Quest Diagnostics Incorporated
7.12.1 Quest Diagnostics Incorporated Details
7.12.2 Quest Diagnostics Incorporated Major Business
7.12.3 Quest Diagnostics Incorporated OTC and DTC Infectious Disease Diagnostic Product and Services
7.12.4 Quest Diagnostics Incorporated OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Quest Diagnostics Incorporated Recent Developments/Updates
7.12.6 Quest Diagnostics Incorporated Competitive Strengths & Weaknesses
7.13 Ador Diagnostics
7.13.1 Ador Diagnostics Details
7.13.2 Ador Diagnostics Major Business
7.13.3 Ador Diagnostics OTC and DTC Infectious Disease Diagnostic Product and Services
7.13.4 Ador Diagnostics OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Ador Diagnostics Recent Developments/Updates
7.13.6 Ador Diagnostics Competitive Strengths & Weaknesses
7.14 Akonni Biosystems, Inc.
7.14.1 Akonni Biosystems, Inc. Details
7.14.2 Akonni Biosystems, Inc. Major Business
7.14.3 Akonni Biosystems, Inc. OTC and DTC Infectious Disease Diagnostic Product and Services
7.14.4 Akonni Biosystems, Inc. OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Akonni Biosystems, Inc. Recent Developments/Updates
7.14.6 Akonni Biosystems, Inc. Competitive Strengths & Weaknesses
7.15 Alveo Technologies
7.15.1 Alveo Technologies Details
7.15.2 Alveo Technologies Major Business
7.15.3 Alveo Technologies OTC and DTC Infectious Disease Diagnostic Product and Services
7.15.4 Alveo Technologies OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Alveo Technologies Recent Developments/Updates
7.15.6 Alveo Technologies Competitive Strengths & Weaknesses
7.16 Binx Health Inc.
7.16.1 Binx Health Inc. Details
7.16.2 Binx Health Inc. Major Business
7.16.3 Binx Health Inc. OTC and DTC Infectious Disease Diagnostic Product and Services
7.16.4 Binx Health Inc. OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Binx Health Inc. Recent Developments/Updates
7.16.6 Binx Health Inc. Competitive Strengths & Weaknesses
7.17 bioM?rieux, Inc.
7.17.1 bioM?rieux, Inc. Details
7.17.2 bioM?rieux, Inc. Major Business
7.17.3 bioM?rieux, Inc. OTC and DTC Infectious Disease Diagnostic Product and Services
7.17.4 bioM?rieux, Inc. OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 bioM?rieux, Inc. Recent Developments/Updates
7.17.6 bioM?rieux, Inc. Competitive Strengths & Weaknesses
7.18 Curetis
7.18.1 Curetis Details
7.18.2 Curetis Major Business
7.18.3 Curetis OTC and DTC Infectious Disease Diagnostic Product and Services
7.18.4 Curetis OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 Curetis Recent Developments/Updates
7.18.6 Curetis Competitive Strengths & Weaknesses
7.19 Sysmex Europe GmbH
7.19.1 Sysmex Europe GmbH Details
7.19.2 Sysmex Europe GmbH Major Business
7.19.3 Sysmex Europe GmbH OTC and DTC Infectious Disease Diagnostic Product and Services
7.19.4 Sysmex Europe GmbH OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
7.19.5 Sysmex Europe GmbH Recent Developments/Updates
7.19.6 Sysmex Europe GmbH Competitive Strengths & Weaknesses
7.20 Diasorin S.p.A
7.20.1 Diasorin S.p.A Details
7.20.2 Diasorin S.p.A Major Business
7.20.3 Diasorin S.p.A OTC and DTC Infectious Disease Diagnostic Product and Services
7.20.4 Diasorin S.p.A OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
7.20.5 Diasorin S.p.A Recent Developments/Updates
7.20.6 Diasorin S.p.A Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 OTC and DTC Infectious Disease Diagnostic Industry Chain
8.2 OTC and DTC Infectious Disease Diagnostic Upstream Analysis
8.3 OTC and DTC Infectious Disease Diagnostic Midstream Analysis
8.4 OTC and DTC Infectious Disease Diagnostic Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 OTC and DTC Infectious Disease Diagnostic Introduction
1.2 World OTC and DTC Infectious Disease Diagnostic Market Size & Forecast (2018 & 2022 & 2029)
1.3 World OTC and DTC Infectious Disease Diagnostic Total Market by Region (by Headquarter Location)
1.3.1 World OTC and DTC Infectious Disease Diagnostic Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States OTC and DTC Infectious Disease Diagnostic Market Size (2018-2029)
1.3.3 China OTC and DTC Infectious Disease Diagnostic Market Size (2018-2029)
1.3.4 Europe OTC and DTC Infectious Disease Diagnostic Market Size (2018-2029)
1.3.5 Japan OTC and DTC Infectious Disease Diagnostic Market Size (2018-2029)
1.3.6 South Korea OTC and DTC Infectious Disease Diagnostic Market Size (2018-2029)
1.3.7 ASEAN OTC and DTC Infectious Disease Diagnostic Market Size (2018-2029)
1.3.8 India OTC and DTC Infectious Disease Diagnostic Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 OTC and DTC Infectious Disease Diagnostic Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 OTC and DTC Infectious Disease Diagnostic Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World OTC and DTC Infectious Disease Diagnostic Consumption Value (2018-2029)
2.2 World OTC and DTC Infectious Disease Diagnostic Consumption Value by Region
2.2.1 World OTC and DTC Infectious Disease Diagnostic Consumption Value by Region (2018-2023)
2.2.2 World OTC and DTC Infectious Disease Diagnostic Consumption Value Forecast by Region (2024-2029)
2.3 United States OTC and DTC Infectious Disease Diagnostic Consumption Value (2018-2029)
2.4 China OTC and DTC Infectious Disease Diagnostic Consumption Value (2018-2029)
2.5 Europe OTC and DTC Infectious Disease Diagnostic Consumption Value (2018-2029)
2.6 Japan OTC and DTC Infectious Disease Diagnostic Consumption Value (2018-2029)
2.7 South Korea OTC and DTC Infectious Disease Diagnostic Consumption Value (2018-2029)
2.8 ASEAN OTC and DTC Infectious Disease Diagnostic Consumption Value (2018-2029)
2.9 India OTC and DTC Infectious Disease Diagnostic Consumption Value (2018-2029)
3 WORLD OTC AND DTC INFECTIOUS DISEASE DIAGNOSTIC COMPANIES COMPETITIVE ANALYSIS
3.1 World OTC and DTC Infectious Disease Diagnostic Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global OTC and DTC Infectious Disease Diagnostic Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for OTC and DTC Infectious Disease Diagnostic in 2022
3.2.3 Global Concentration Ratios (CR8) for OTC and DTC Infectious Disease Diagnostic in 2022
3.3 OTC and DTC Infectious Disease Diagnostic Company Evaluation Quadrant
3.4 OTC and DTC Infectious Disease Diagnostic Market: Overall Company Footprint Analysis
3.4.1 OTC and DTC Infectious Disease Diagnostic Market: Region Footprint
3.4.2 OTC and DTC Infectious Disease Diagnostic Market: Company Product Type Footprint
3.4.3 OTC and DTC Infectious Disease Diagnostic Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: OTC and DTC Infectious Disease Diagnostic Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: OTC and DTC Infectious Disease Diagnostic Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: OTC and DTC Infectious Disease Diagnostic Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: OTC and DTC Infectious Disease Diagnostic Consumption Value Comparison
4.2.1 United States VS China: OTC and DTC Infectious Disease Diagnostic Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: OTC and DTC Infectious Disease Diagnostic Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based OTC and DTC Infectious Disease Diagnostic Companies and Market Share, 2018-2023
4.3.1 United States Based OTC and DTC Infectious Disease Diagnostic Companies, Headquarters (States, Country)
4.3.2 United States Based Companies OTC and DTC Infectious Disease Diagnostic Revenue, (2018-2023)
4.4 China Based Companies OTC and DTC Infectious Disease Diagnostic Revenue and Market Share, 2018-2023
4.4.1 China Based OTC and DTC Infectious Disease Diagnostic Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies OTC and DTC Infectious Disease Diagnostic Revenue, (2018-2023)
4.5 Rest of World Based OTC and DTC Infectious Disease Diagnostic Companies and Market Share, 2018-2023
4.5.1 Rest of World Based OTC and DTC Infectious Disease Diagnostic Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies OTC and DTC Infectious Disease Diagnostic Revenue, (2018-2023)
5 MARKET ANALYSIS BY TECHNOLOGY
5.1 World OTC and DTC Infectious Disease Diagnostic Market Size Overview by Technology: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Technology
5.2.1 PCR
5.2.2 Immunodiagnostics
5.2.3 Clinical Microbiology
5.2.4 INAAT
5.2.5 DNA Sequencing and NGS
5.2.6 DNA Microarrays
5.2.7 Others
5.3 Market Segment by Technology
5.3.1 World OTC and DTC Infectious Disease Diagnostic Market Size by Technology (2018-2023)
5.3.2 World OTC and DTC Infectious Disease Diagnostic Market Size by Technology (2024-2029)
5.3.3 World OTC and DTC Infectious Disease Diagnostic Market Size Market Share by Technology (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World OTC and DTC Infectious Disease Diagnostic Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Diagnostic Laboratories
6.2.2 Hospitals and Clinics
6.2.3 Academic Research Institutes
6.2.4 Others
6.2.5 Others
6.3 Market Segment by Application
6.3.1 World OTC and DTC Infectious Disease Diagnostic Market Size by Application (2018-2023)
6.3.2 World OTC and DTC Infectious Disease Diagnostic Market Size by Application (2024-2029)
6.3.3 World OTC and DTC Infectious Disease Diagnostic Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Abbott
7.1.1 Abbott Details
7.1.2 Abbott Major Business
7.1.3 Abbott OTC and DTC Infectious Disease Diagnostic Product and Services
7.1.4 Abbott OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Abbott Recent Developments/Updates
7.1.6 Abbott Competitive Strengths & Weaknesses
7.2 Bio-Rad Laboratories Inc
7.2.1 Bio-Rad Laboratories Inc Details
7.2.2 Bio-Rad Laboratories Inc Major Business
7.2.3 Bio-Rad Laboratories Inc OTC and DTC Infectious Disease Diagnostic Product and Services
7.2.4 Bio-Rad Laboratories Inc OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Bio-Rad Laboratories Inc Recent Developments/Updates
7.2.6 Bio-Rad Laboratories Inc Competitive Strengths & Weaknesses
7.3 BD
7.3.1 BD Details
7.3.2 BD Major Business
7.3.3 BD OTC and DTC Infectious Disease Diagnostic Product and Services
7.3.4 BD OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 BD Recent Developments/Updates
7.3.6 BD Competitive Strengths & Weaknesses
7.4 Bosch Healthcare Solutions GmbH
7.4.1 Bosch Healthcare Solutions GmbH Details
7.4.2 Bosch Healthcare Solutions GmbH Major Business
7.4.3 Bosch Healthcare Solutions GmbH OTC and DTC Infectious Disease Diagnostic Product and Services
7.4.4 Bosch Healthcare Solutions GmbH OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Bosch Healthcare Solutions GmbH Recent Developments/Updates
7.4.6 Bosch Healthcare Solutions GmbH Competitive Strengths & Weaknesses
7.5 Danaher
7.5.1 Danaher Details
7.5.2 Danaher Major Business
7.5.3 Danaher OTC and DTC Infectious Disease Diagnostic Product and Services
7.5.4 Danaher OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Danaher Recent Developments/Updates
7.5.6 Danaher Competitive Strengths & Weaknesses
7.6 ThermoFisher Scientific
7.6.1 ThermoFisher Scientific Details
7.6.2 ThermoFisher Scientific Major Business
7.6.3 ThermoFisher Scientific OTC and DTC Infectious Disease Diagnostic Product and Services
7.6.4 ThermoFisher Scientific OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 ThermoFisher Scientific Recent Developments/Updates
7.6.6 ThermoFisher Scientific Competitive Strengths & Weaknesses
7.7 Siemens AG
7.7.1 Siemens AG Details
7.7.2 Siemens AG Major Business
7.7.3 Siemens AG OTC and DTC Infectious Disease Diagnostic Product and Services
7.7.4 Siemens AG OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Siemens AG Recent Developments/Updates
7.7.6 Siemens AG Competitive Strengths & Weaknesses
7.8 Roche Holding AG
7.8.1 Roche Holding AG Details
7.8.2 Roche Holding AG Major Business
7.8.3 Roche Holding AG OTC and DTC Infectious Disease Diagnostic Product and Services
7.8.4 Roche Holding AG OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Roche Holding AG Recent Developments/Updates
7.8.6 Roche Holding AG Competitive Strengths & Weaknesses
7.9 Hologic, Inc.
7.9.1 Hologic, Inc. Details
7.9.2 Hologic, Inc. Major Business
7.9.3 Hologic, Inc. OTC and DTC Infectious Disease Diagnostic Product and Services
7.9.4 Hologic, Inc. OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Hologic, Inc. Recent Developments/Updates
7.9.6 Hologic, Inc. Competitive Strengths & Weaknesses
7.10 Qiagen
7.10.1 Qiagen Details
7.10.2 Qiagen Major Business
7.10.3 Qiagen OTC and DTC Infectious Disease Diagnostic Product and Services
7.10.4 Qiagen OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Qiagen Recent Developments/Updates
7.10.6 Qiagen Competitive Strengths & Weaknesses
7.11 Cardinal Health
7.11.1 Cardinal Health Details
7.11.2 Cardinal Health Major Business
7.11.3 Cardinal Health OTC and DTC Infectious Disease Diagnostic Product and Services
7.11.4 Cardinal Health OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Cardinal Health Recent Developments/Updates
7.11.6 Cardinal Health Competitive Strengths & Weaknesses
7.12 Quest Diagnostics Incorporated
7.12.1 Quest Diagnostics Incorporated Details
7.12.2 Quest Diagnostics Incorporated Major Business
7.12.3 Quest Diagnostics Incorporated OTC and DTC Infectious Disease Diagnostic Product and Services
7.12.4 Quest Diagnostics Incorporated OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Quest Diagnostics Incorporated Recent Developments/Updates
7.12.6 Quest Diagnostics Incorporated Competitive Strengths & Weaknesses
7.13 Ador Diagnostics
7.13.1 Ador Diagnostics Details
7.13.2 Ador Diagnostics Major Business
7.13.3 Ador Diagnostics OTC and DTC Infectious Disease Diagnostic Product and Services
7.13.4 Ador Diagnostics OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Ador Diagnostics Recent Developments/Updates
7.13.6 Ador Diagnostics Competitive Strengths & Weaknesses
7.14 Akonni Biosystems, Inc.
7.14.1 Akonni Biosystems, Inc. Details
7.14.2 Akonni Biosystems, Inc. Major Business
7.14.3 Akonni Biosystems, Inc. OTC and DTC Infectious Disease Diagnostic Product and Services
7.14.4 Akonni Biosystems, Inc. OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Akonni Biosystems, Inc. Recent Developments/Updates
7.14.6 Akonni Biosystems, Inc. Competitive Strengths & Weaknesses
7.15 Alveo Technologies
7.15.1 Alveo Technologies Details
7.15.2 Alveo Technologies Major Business
7.15.3 Alveo Technologies OTC and DTC Infectious Disease Diagnostic Product and Services
7.15.4 Alveo Technologies OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Alveo Technologies Recent Developments/Updates
7.15.6 Alveo Technologies Competitive Strengths & Weaknesses
7.16 Binx Health Inc.
7.16.1 Binx Health Inc. Details
7.16.2 Binx Health Inc. Major Business
7.16.3 Binx Health Inc. OTC and DTC Infectious Disease Diagnostic Product and Services
7.16.4 Binx Health Inc. OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Binx Health Inc. Recent Developments/Updates
7.16.6 Binx Health Inc. Competitive Strengths & Weaknesses
7.17 bioM?rieux, Inc.
7.17.1 bioM?rieux, Inc. Details
7.17.2 bioM?rieux, Inc. Major Business
7.17.3 bioM?rieux, Inc. OTC and DTC Infectious Disease Diagnostic Product and Services
7.17.4 bioM?rieux, Inc. OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 bioM?rieux, Inc. Recent Developments/Updates
7.17.6 bioM?rieux, Inc. Competitive Strengths & Weaknesses
7.18 Curetis
7.18.1 Curetis Details
7.18.2 Curetis Major Business
7.18.3 Curetis OTC and DTC Infectious Disease Diagnostic Product and Services
7.18.4 Curetis OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 Curetis Recent Developments/Updates
7.18.6 Curetis Competitive Strengths & Weaknesses
7.19 Sysmex Europe GmbH
7.19.1 Sysmex Europe GmbH Details
7.19.2 Sysmex Europe GmbH Major Business
7.19.3 Sysmex Europe GmbH OTC and DTC Infectious Disease Diagnostic Product and Services
7.19.4 Sysmex Europe GmbH OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
7.19.5 Sysmex Europe GmbH Recent Developments/Updates
7.19.6 Sysmex Europe GmbH Competitive Strengths & Weaknesses
7.20 Diasorin S.p.A
7.20.1 Diasorin S.p.A Details
7.20.2 Diasorin S.p.A Major Business
7.20.3 Diasorin S.p.A OTC and DTC Infectious Disease Diagnostic Product and Services
7.20.4 Diasorin S.p.A OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
7.20.5 Diasorin S.p.A Recent Developments/Updates
7.20.6 Diasorin S.p.A Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 OTC and DTC Infectious Disease Diagnostic Industry Chain
8.2 OTC and DTC Infectious Disease Diagnostic Upstream Analysis
8.3 OTC and DTC Infectious Disease Diagnostic Midstream Analysis
8.4 OTC and DTC Infectious Disease Diagnostic Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World OTC and DTC Infectious Disease Diagnostic Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World OTC and DTC Infectious Disease Diagnostic Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World OTC and DTC Infectious Disease Diagnostic Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World OTC and DTC Infectious Disease Diagnostic Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World OTC and DTC Infectious Disease Diagnostic Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World OTC and DTC Infectious Disease Diagnostic Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World OTC and DTC Infectious Disease Diagnostic Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World OTC and DTC Infectious Disease Diagnostic Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World OTC and DTC Infectious Disease Diagnostic Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key OTC and DTC Infectious Disease Diagnostic Players in 2022
Table 12. World OTC and DTC Infectious Disease Diagnostic Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global OTC and DTC Infectious Disease Diagnostic Company Evaluation Quadrant
Table 14. Head Office of Key OTC and DTC Infectious Disease Diagnostic Player
Table 15. OTC and DTC Infectious Disease Diagnostic Market: Company Product Type Footprint
Table 16. OTC and DTC Infectious Disease Diagnostic Market: Company Product Application Footprint
Table 17. OTC and DTC Infectious Disease Diagnostic Mergers & Acquisitions Activity
Table 18. United States VS China OTC and DTC Infectious Disease Diagnostic Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China OTC and DTC Infectious Disease Diagnostic Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based OTC and DTC Infectious Disease Diagnostic Companies, Headquarters (States, Country)
Table 21. United States Based Companies OTC and DTC Infectious Disease Diagnostic Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies OTC and DTC Infectious Disease Diagnostic Revenue Market Share (2018-2023)
Table 23. China Based OTC and DTC Infectious Disease Diagnostic Companies, Headquarters (Province, Country)
Table 24. China Based Companies OTC and DTC Infectious Disease Diagnostic Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies OTC and DTC Infectious Disease Diagnostic Revenue Market Share (2018-2023)
Table 26. Rest of World Based OTC and DTC Infectious Disease Diagnostic Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies OTC and DTC Infectious Disease Diagnostic Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies OTC and DTC Infectious Disease Diagnostic Revenue Market Share (2018-2023)
Table 29. World OTC and DTC Infectious Disease Diagnostic Market Size by Technology, (USD Million), 2018 & 2022 & 2029
Table 30. World OTC and DTC Infectious Disease Diagnostic Market Size by Technology (2018-2023) & (USD Million)
Table 31. World OTC and DTC Infectious Disease Diagnostic Market Size by Technology (2024-2029) & (USD Million)
Table 32. World OTC and DTC Infectious Disease Diagnostic Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World OTC and DTC Infectious Disease Diagnostic Market Size by Application (2018-2023) & (USD Million)
Table 34. World OTC and DTC Infectious Disease Diagnostic Market Size by Application (2024-2029) & (USD Million)
Table 35. Abbott Basic Information, Area Served and Competitors
Table 36. Abbott Major Business
Table 37. Abbott OTC and DTC Infectious Disease Diagnostic Product and Services
Table 38. Abbott OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Abbott Recent Developments/Updates
Table 40. Abbott Competitive Strengths & Weaknesses
Table 41. Bio-Rad Laboratories Inc Basic Information, Area Served and Competitors
Table 42. Bio-Rad Laboratories Inc Major Business
Table 43. Bio-Rad Laboratories Inc OTC and DTC Infectious Disease Diagnostic Product and Services
Table 44. Bio-Rad Laboratories Inc OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Bio-Rad Laboratories Inc Recent Developments/Updates
Table 46. Bio-Rad Laboratories Inc Competitive Strengths & Weaknesses
Table 47. BD Basic Information, Area Served and Competitors
Table 48. BD Major Business
Table 49. BD OTC and DTC Infectious Disease Diagnostic Product and Services
Table 50. BD OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. BD Recent Developments/Updates
Table 52. BD Competitive Strengths & Weaknesses
Table 53. Bosch Healthcare Solutions GmbH Basic Information, Area Served and Competitors
Table 54. Bosch Healthcare Solutions GmbH Major Business
Table 55. Bosch Healthcare Solutions GmbH OTC and DTC Infectious Disease Diagnostic Product and Services
Table 56. Bosch Healthcare Solutions GmbH OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Bosch Healthcare Solutions GmbH Recent Developments/Updates
Table 58. Bosch Healthcare Solutions GmbH Competitive Strengths & Weaknesses
Table 59. Danaher Basic Information, Area Served and Competitors
Table 60. Danaher Major Business
Table 61. Danaher OTC and DTC Infectious Disease Diagnostic Product and Services
Table 62. Danaher OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Danaher Recent Developments/Updates
Table 64. Danaher Competitive Strengths & Weaknesses
Table 65. ThermoFisher Scientific Basic Information, Area Served and Competitors
Table 66. ThermoFisher Scientific Major Business
Table 67. ThermoFisher Scientific OTC and DTC Infectious Disease Diagnostic Product and Services
Table 68. ThermoFisher Scientific OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. ThermoFisher Scientific Recent Developments/Updates
Table 70. ThermoFisher Scientific Competitive Strengths & Weaknesses
Table 71. Siemens AG Basic Information, Area Served and Competitors
Table 72. Siemens AG Major Business
Table 73. Siemens AG OTC and DTC Infectious Disease Diagnostic Product and Services
Table 74. Siemens AG OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Siemens AG Recent Developments/Updates
Table 76. Siemens AG Competitive Strengths & Weaknesses
Table 77. Roche Holding AG Basic Information, Area Served and Competitors
Table 78. Roche Holding AG Major Business
Table 79. Roche Holding AG OTC and DTC Infectious Disease Diagnostic Product and Services
Table 80. Roche Holding AG OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Roche Holding AG Recent Developments/Updates
Table 82. Roche Holding AG Competitive Strengths & Weaknesses
Table 83. Hologic, Inc. Basic Information, Area Served and Competitors
Table 84. Hologic, Inc. Major Business
Table 85. Hologic, Inc. OTC and DTC Infectious Disease Diagnostic Product and Services
Table 86. Hologic, Inc. OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Hologic, Inc. Recent Developments/Updates
Table 88. Hologic, Inc. Competitive Strengths & Weaknesses
Table 89. Qiagen Basic Information, Area Served and Competitors
Table 90. Qiagen Major Business
Table 91. Qiagen OTC and DTC Infectious Disease Diagnostic Product and Services
Table 92. Qiagen OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Qiagen Recent Developments/Updates
Table 94. Qiagen Competitive Strengths & Weaknesses
Table 95. Cardinal Health Basic Information, Area Served and Competitors
Table 96. Cardinal Health Major Business
Table 97. Cardinal Health OTC and DTC Infectious Disease Diagnostic Product and Services
Table 98. Cardinal Health OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Cardinal Health Recent Developments/Updates
Table 100. Cardinal Health Competitive Strengths & Weaknesses
Table 101. Quest Diagnostics Incorporated Basic Information, Area Served and Competitors
Table 102. Quest Diagnostics Incorporated Major Business
Table 103. Quest Diagnostics Incorporated OTC and DTC Infectious Disease Diagnostic Product and Services
Table 104. Quest Diagnostics Incorporated OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Quest Diagnostics Incorporated Recent Developments/Updates
Table 106. Quest Diagnostics Incorporated Competitive Strengths & Weaknesses
Table 107. Ador Diagnostics Basic Information, Area Served and Competitors
Table 108. Ador Diagnostics Major Business
Table 109. Ador Diagnostics OTC and DTC Infectious Disease Diagnostic Product and Services
Table 110. Ador Diagnostics OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Ador Diagnostics Recent Developments/Updates
Table 112. Ador Diagnostics Competitive Strengths & Weaknesses
Table 113. Akonni Biosystems, Inc. Basic Information, Area Served and Competitors
Table 114. Akonni Biosystems, Inc. Major Business
Table 115. Akonni Biosystems, Inc. OTC and DTC Infectious Disease Diagnostic Product and Services
Table 116. Akonni Biosystems, Inc. OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Akonni Biosystems, Inc. Recent Developments/Updates
Table 118. Akonni Biosystems, Inc. Competitive Strengths & Weaknesses
Table 119. Alveo Technologies Basic Information, Area Served and Competitors
Table 120. Alveo Technologies Major Business
Table 121. Alveo Technologies OTC and DTC Infectious Disease Diagnostic Product and Services
Table 122. Alveo Technologies OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Alveo Technologies Recent Developments/Updates
Table 124. Alveo Technologies Competitive Strengths & Weaknesses
Table 125. Binx Health Inc. Basic Information, Area Served and Competitors
Table 126. Binx Health Inc. Major Business
Table 127. Binx Health Inc. OTC and DTC Infectious Disease Diagnostic Product and Services
Table 128. Binx Health Inc. OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Binx Health Inc. Recent Developments/Updates
Table 130. Binx Health Inc. Competitive Strengths & Weaknesses
Table 131. bioM?rieux, Inc. Basic Information, Area Served and Competitors
Table 132. bioM?rieux, Inc. Major Business
Table 133. bioM?rieux, Inc. OTC and DTC Infectious Disease Diagnostic Product and Services
Table 134. bioM?rieux, Inc. OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. bioM?rieux, Inc. Recent Developments/Updates
Table 136. bioM?rieux, Inc. Competitive Strengths & Weaknesses
Table 137. Curetis Basic Information, Area Served and Competitors
Table 138. Curetis Major Business
Table 139. Curetis OTC and DTC Infectious Disease Diagnostic Product and Services
Table 140. Curetis OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. Curetis Recent Developments/Updates
Table 142. Curetis Competitive Strengths & Weaknesses
Table 143. Sysmex Europe GmbH Basic Information, Area Served and Competitors
Table 144. Sysmex Europe GmbH Major Business
Table 145. Sysmex Europe GmbH OTC and DTC Infectious Disease Diagnostic Product and Services
Table 146. Sysmex Europe GmbH OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 147. Sysmex Europe GmbH Recent Developments/Updates
Table 148. Diasorin S.p.A Basic Information, Area Served and Competitors
Table 149. Diasorin S.p.A Major Business
Table 150. Diasorin S.p.A OTC and DTC Infectious Disease Diagnostic Product and Services
Table 151. Diasorin S.p.A OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 152. Global Key Players of OTC and DTC Infectious Disease Diagnostic Upstream (Raw Materials)
Table 153. OTC and DTC Infectious Disease Diagnostic Typical Customers
Table 1. World OTC and DTC Infectious Disease Diagnostic Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World OTC and DTC Infectious Disease Diagnostic Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World OTC and DTC Infectious Disease Diagnostic Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World OTC and DTC Infectious Disease Diagnostic Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World OTC and DTC Infectious Disease Diagnostic Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World OTC and DTC Infectious Disease Diagnostic Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World OTC and DTC Infectious Disease Diagnostic Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World OTC and DTC Infectious Disease Diagnostic Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World OTC and DTC Infectious Disease Diagnostic Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key OTC and DTC Infectious Disease Diagnostic Players in 2022
Table 12. World OTC and DTC Infectious Disease Diagnostic Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global OTC and DTC Infectious Disease Diagnostic Company Evaluation Quadrant
Table 14. Head Office of Key OTC and DTC Infectious Disease Diagnostic Player
Table 15. OTC and DTC Infectious Disease Diagnostic Market: Company Product Type Footprint
Table 16. OTC and DTC Infectious Disease Diagnostic Market: Company Product Application Footprint
Table 17. OTC and DTC Infectious Disease Diagnostic Mergers & Acquisitions Activity
Table 18. United States VS China OTC and DTC Infectious Disease Diagnostic Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China OTC and DTC Infectious Disease Diagnostic Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based OTC and DTC Infectious Disease Diagnostic Companies, Headquarters (States, Country)
Table 21. United States Based Companies OTC and DTC Infectious Disease Diagnostic Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies OTC and DTC Infectious Disease Diagnostic Revenue Market Share (2018-2023)
Table 23. China Based OTC and DTC Infectious Disease Diagnostic Companies, Headquarters (Province, Country)
Table 24. China Based Companies OTC and DTC Infectious Disease Diagnostic Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies OTC and DTC Infectious Disease Diagnostic Revenue Market Share (2018-2023)
Table 26. Rest of World Based OTC and DTC Infectious Disease Diagnostic Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies OTC and DTC Infectious Disease Diagnostic Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies OTC and DTC Infectious Disease Diagnostic Revenue Market Share (2018-2023)
Table 29. World OTC and DTC Infectious Disease Diagnostic Market Size by Technology, (USD Million), 2018 & 2022 & 2029
Table 30. World OTC and DTC Infectious Disease Diagnostic Market Size by Technology (2018-2023) & (USD Million)
Table 31. World OTC and DTC Infectious Disease Diagnostic Market Size by Technology (2024-2029) & (USD Million)
Table 32. World OTC and DTC Infectious Disease Diagnostic Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World OTC and DTC Infectious Disease Diagnostic Market Size by Application (2018-2023) & (USD Million)
Table 34. World OTC and DTC Infectious Disease Diagnostic Market Size by Application (2024-2029) & (USD Million)
Table 35. Abbott Basic Information, Area Served and Competitors
Table 36. Abbott Major Business
Table 37. Abbott OTC and DTC Infectious Disease Diagnostic Product and Services
Table 38. Abbott OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Abbott Recent Developments/Updates
Table 40. Abbott Competitive Strengths & Weaknesses
Table 41. Bio-Rad Laboratories Inc Basic Information, Area Served and Competitors
Table 42. Bio-Rad Laboratories Inc Major Business
Table 43. Bio-Rad Laboratories Inc OTC and DTC Infectious Disease Diagnostic Product and Services
Table 44. Bio-Rad Laboratories Inc OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Bio-Rad Laboratories Inc Recent Developments/Updates
Table 46. Bio-Rad Laboratories Inc Competitive Strengths & Weaknesses
Table 47. BD Basic Information, Area Served and Competitors
Table 48. BD Major Business
Table 49. BD OTC and DTC Infectious Disease Diagnostic Product and Services
Table 50. BD OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. BD Recent Developments/Updates
Table 52. BD Competitive Strengths & Weaknesses
Table 53. Bosch Healthcare Solutions GmbH Basic Information, Area Served and Competitors
Table 54. Bosch Healthcare Solutions GmbH Major Business
Table 55. Bosch Healthcare Solutions GmbH OTC and DTC Infectious Disease Diagnostic Product and Services
Table 56. Bosch Healthcare Solutions GmbH OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Bosch Healthcare Solutions GmbH Recent Developments/Updates
Table 58. Bosch Healthcare Solutions GmbH Competitive Strengths & Weaknesses
Table 59. Danaher Basic Information, Area Served and Competitors
Table 60. Danaher Major Business
Table 61. Danaher OTC and DTC Infectious Disease Diagnostic Product and Services
Table 62. Danaher OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Danaher Recent Developments/Updates
Table 64. Danaher Competitive Strengths & Weaknesses
Table 65. ThermoFisher Scientific Basic Information, Area Served and Competitors
Table 66. ThermoFisher Scientific Major Business
Table 67. ThermoFisher Scientific OTC and DTC Infectious Disease Diagnostic Product and Services
Table 68. ThermoFisher Scientific OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. ThermoFisher Scientific Recent Developments/Updates
Table 70. ThermoFisher Scientific Competitive Strengths & Weaknesses
Table 71. Siemens AG Basic Information, Area Served and Competitors
Table 72. Siemens AG Major Business
Table 73. Siemens AG OTC and DTC Infectious Disease Diagnostic Product and Services
Table 74. Siemens AG OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Siemens AG Recent Developments/Updates
Table 76. Siemens AG Competitive Strengths & Weaknesses
Table 77. Roche Holding AG Basic Information, Area Served and Competitors
Table 78. Roche Holding AG Major Business
Table 79. Roche Holding AG OTC and DTC Infectious Disease Diagnostic Product and Services
Table 80. Roche Holding AG OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Roche Holding AG Recent Developments/Updates
Table 82. Roche Holding AG Competitive Strengths & Weaknesses
Table 83. Hologic, Inc. Basic Information, Area Served and Competitors
Table 84. Hologic, Inc. Major Business
Table 85. Hologic, Inc. OTC and DTC Infectious Disease Diagnostic Product and Services
Table 86. Hologic, Inc. OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Hologic, Inc. Recent Developments/Updates
Table 88. Hologic, Inc. Competitive Strengths & Weaknesses
Table 89. Qiagen Basic Information, Area Served and Competitors
Table 90. Qiagen Major Business
Table 91. Qiagen OTC and DTC Infectious Disease Diagnostic Product and Services
Table 92. Qiagen OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Qiagen Recent Developments/Updates
Table 94. Qiagen Competitive Strengths & Weaknesses
Table 95. Cardinal Health Basic Information, Area Served and Competitors
Table 96. Cardinal Health Major Business
Table 97. Cardinal Health OTC and DTC Infectious Disease Diagnostic Product and Services
Table 98. Cardinal Health OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Cardinal Health Recent Developments/Updates
Table 100. Cardinal Health Competitive Strengths & Weaknesses
Table 101. Quest Diagnostics Incorporated Basic Information, Area Served and Competitors
Table 102. Quest Diagnostics Incorporated Major Business
Table 103. Quest Diagnostics Incorporated OTC and DTC Infectious Disease Diagnostic Product and Services
Table 104. Quest Diagnostics Incorporated OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Quest Diagnostics Incorporated Recent Developments/Updates
Table 106. Quest Diagnostics Incorporated Competitive Strengths & Weaknesses
Table 107. Ador Diagnostics Basic Information, Area Served and Competitors
Table 108. Ador Diagnostics Major Business
Table 109. Ador Diagnostics OTC and DTC Infectious Disease Diagnostic Product and Services
Table 110. Ador Diagnostics OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Ador Diagnostics Recent Developments/Updates
Table 112. Ador Diagnostics Competitive Strengths & Weaknesses
Table 113. Akonni Biosystems, Inc. Basic Information, Area Served and Competitors
Table 114. Akonni Biosystems, Inc. Major Business
Table 115. Akonni Biosystems, Inc. OTC and DTC Infectious Disease Diagnostic Product and Services
Table 116. Akonni Biosystems, Inc. OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Akonni Biosystems, Inc. Recent Developments/Updates
Table 118. Akonni Biosystems, Inc. Competitive Strengths & Weaknesses
Table 119. Alveo Technologies Basic Information, Area Served and Competitors
Table 120. Alveo Technologies Major Business
Table 121. Alveo Technologies OTC and DTC Infectious Disease Diagnostic Product and Services
Table 122. Alveo Technologies OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Alveo Technologies Recent Developments/Updates
Table 124. Alveo Technologies Competitive Strengths & Weaknesses
Table 125. Binx Health Inc. Basic Information, Area Served and Competitors
Table 126. Binx Health Inc. Major Business
Table 127. Binx Health Inc. OTC and DTC Infectious Disease Diagnostic Product and Services
Table 128. Binx Health Inc. OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Binx Health Inc. Recent Developments/Updates
Table 130. Binx Health Inc. Competitive Strengths & Weaknesses
Table 131. bioM?rieux, Inc. Basic Information, Area Served and Competitors
Table 132. bioM?rieux, Inc. Major Business
Table 133. bioM?rieux, Inc. OTC and DTC Infectious Disease Diagnostic Product and Services
Table 134. bioM?rieux, Inc. OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. bioM?rieux, Inc. Recent Developments/Updates
Table 136. bioM?rieux, Inc. Competitive Strengths & Weaknesses
Table 137. Curetis Basic Information, Area Served and Competitors
Table 138. Curetis Major Business
Table 139. Curetis OTC and DTC Infectious Disease Diagnostic Product and Services
Table 140. Curetis OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. Curetis Recent Developments/Updates
Table 142. Curetis Competitive Strengths & Weaknesses
Table 143. Sysmex Europe GmbH Basic Information, Area Served and Competitors
Table 144. Sysmex Europe GmbH Major Business
Table 145. Sysmex Europe GmbH OTC and DTC Infectious Disease Diagnostic Product and Services
Table 146. Sysmex Europe GmbH OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 147. Sysmex Europe GmbH Recent Developments/Updates
Table 148. Diasorin S.p.A Basic Information, Area Served and Competitors
Table 149. Diasorin S.p.A Major Business
Table 150. Diasorin S.p.A OTC and DTC Infectious Disease Diagnostic Product and Services
Table 151. Diasorin S.p.A OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 152. Global Key Players of OTC and DTC Infectious Disease Diagnostic Upstream (Raw Materials)
Table 153. OTC and DTC Infectious Disease Diagnostic Typical Customers
LIST OF FIGURES
Figure 1. OTC and DTC Infectious Disease Diagnostic Picture
Figure 2. World OTC and DTC Infectious Disease Diagnostic Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World OTC and DTC Infectious Disease Diagnostic Total Market Size (2018-2029) & (USD Million)
Figure 4. World OTC and DTC Infectious Disease Diagnostic Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World OTC and DTC Infectious Disease Diagnostic Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company OTC and DTC Infectious Disease Diagnostic Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company OTC and DTC Infectious Disease Diagnostic Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company OTC and DTC Infectious Disease Diagnostic Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company OTC and DTC Infectious Disease Diagnostic Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company OTC and DTC Infectious Disease Diagnostic Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company OTC and DTC Infectious Disease Diagnostic Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company OTC and DTC Infectious Disease Diagnostic Revenue (2018-2029) & (USD Million)
Figure 13. OTC and DTC Infectious Disease Diagnostic Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World OTC and DTC Infectious Disease Diagnostic Consumption Value (2018-2029) & (USD Million)
Figure 16. World OTC and DTC Infectious Disease Diagnostic Consumption Value Market Share by Region (2018-2029)
Figure 17. United States OTC and DTC Infectious Disease Diagnostic Consumption Value (2018-2029) & (USD Million)
Figure 18. China OTC and DTC Infectious Disease Diagnostic Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe OTC and DTC Infectious Disease Diagnostic Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan OTC and DTC Infectious Disease Diagnostic Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea OTC and DTC Infectious Disease Diagnostic Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN OTC and DTC Infectious Disease Diagnostic Consumption Value (2018-2029) & (USD Million)
Figure 23. India OTC and DTC Infectious Disease Diagnostic Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of OTC and DTC Infectious Disease Diagnostic by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for OTC and DTC Infectious Disease Diagnostic Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for OTC and DTC Infectious Disease Diagnostic Markets in 2022
Figure 27. United States VS China: OTC and DTC Infectious Disease Diagnostic Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: OTC and DTC Infectious Disease Diagnostic Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World OTC and DTC Infectious Disease Diagnostic Market Size by Technology, (USD Million), 2018 & 2022 & 2029
Figure 30. World OTC and DTC Infectious Disease Diagnostic Market Size Market Share by Technology in 2022
Figure 31. PCR
Figure 32. Immunodiagnostics
Figure 33. Clinical Microbiology
Figure 34. INAAT
Figure 35. DNA Sequencing and NGS
Figure 36. DNA Microarrays
Figure 37. Others
Figure 38. World OTC and DTC Infectious Disease Diagnostic Market Size Market Share by Technology (2018-2029)
Figure 39. World OTC and DTC Infectious Disease Diagnostic Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World OTC and DTC Infectious Disease Diagnostic Market Size Market Share by Application in 2022
Figure 41. Diagnostic Laboratories
Figure 42. Hospitals and Clinics
Figure 43. Academic Research Institutes
Figure 44. Others
Figure 45. OTC and DTC Infectious Disease Diagnostic Industrial Chain
Figure 46. Methodology
Figure 47. Research Process and Data Source
Figure 1. OTC and DTC Infectious Disease Diagnostic Picture
Figure 2. World OTC and DTC Infectious Disease Diagnostic Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World OTC and DTC Infectious Disease Diagnostic Total Market Size (2018-2029) & (USD Million)
Figure 4. World OTC and DTC Infectious Disease Diagnostic Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World OTC and DTC Infectious Disease Diagnostic Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company OTC and DTC Infectious Disease Diagnostic Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company OTC and DTC Infectious Disease Diagnostic Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company OTC and DTC Infectious Disease Diagnostic Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company OTC and DTC Infectious Disease Diagnostic Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company OTC and DTC Infectious Disease Diagnostic Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company OTC and DTC Infectious Disease Diagnostic Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company OTC and DTC Infectious Disease Diagnostic Revenue (2018-2029) & (USD Million)
Figure 13. OTC and DTC Infectious Disease Diagnostic Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World OTC and DTC Infectious Disease Diagnostic Consumption Value (2018-2029) & (USD Million)
Figure 16. World OTC and DTC Infectious Disease Diagnostic Consumption Value Market Share by Region (2018-2029)
Figure 17. United States OTC and DTC Infectious Disease Diagnostic Consumption Value (2018-2029) & (USD Million)
Figure 18. China OTC and DTC Infectious Disease Diagnostic Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe OTC and DTC Infectious Disease Diagnostic Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan OTC and DTC Infectious Disease Diagnostic Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea OTC and DTC Infectious Disease Diagnostic Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN OTC and DTC Infectious Disease Diagnostic Consumption Value (2018-2029) & (USD Million)
Figure 23. India OTC and DTC Infectious Disease Diagnostic Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of OTC and DTC Infectious Disease Diagnostic by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for OTC and DTC Infectious Disease Diagnostic Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for OTC and DTC Infectious Disease Diagnostic Markets in 2022
Figure 27. United States VS China: OTC and DTC Infectious Disease Diagnostic Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: OTC and DTC Infectious Disease Diagnostic Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World OTC and DTC Infectious Disease Diagnostic Market Size by Technology, (USD Million), 2018 & 2022 & 2029
Figure 30. World OTC and DTC Infectious Disease Diagnostic Market Size Market Share by Technology in 2022
Figure 31. PCR
Figure 32. Immunodiagnostics
Figure 33. Clinical Microbiology
Figure 34. INAAT
Figure 35. DNA Sequencing and NGS
Figure 36. DNA Microarrays
Figure 37. Others
Figure 38. World OTC and DTC Infectious Disease Diagnostic Market Size Market Share by Technology (2018-2029)
Figure 39. World OTC and DTC Infectious Disease Diagnostic Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World OTC and DTC Infectious Disease Diagnostic Market Size Market Share by Application in 2022
Figure 41. Diagnostic Laboratories
Figure 42. Hospitals and Clinics
Figure 43. Academic Research Institutes
Figure 44. Others
Figure 45. OTC and DTC Infectious Disease Diagnostic Industrial Chain
Figure 46. Methodology
Figure 47. Research Process and Data Source
